Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.
about
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodiesNeutrophils mediate antibody-induced antitumor effects in mice.Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.Mouse and human FcR effector functions.bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression.The many faces of FcγRI: implications for therapeutic antibody function.Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.
P2860
Q30303054-695332E2-EDCB-4B4A-BDDC-FDA9627DBD62Q37125759-43E134E7-9D19-40DB-AB9A-325C7909EAC5Q37272029-22D25DBF-AC0B-4F6D-87B4-80F93FED9AF0Q37379398-C2DE0530-30C9-486E-AA33-D07D61B3514FQ38615349-4830FA89-C55B-4042-9088-8978B05F9983Q38615353-D84D098B-5BC3-4D3F-B29D-D0EFEA3B23CBQ38615362-1F376E38-C948-4C5D-91DF-34E6B040503BQ38787705-1D228664-1194-4BC9-AF78-22C27868277CQ40103834-B771C892-B259-446C-A493-94842EAA271AQ41945124-5A813DD5-3484-4DB3-9817-839BAA91F094Q50445792-E82C3581-374D-4591-829D-A4B25B157100
P2860
Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cutting edge: FcγRIII (CD16) a ...... ental metastatic B16 melanoma.
@en
Cutting edge: FcγRIII
@nl
type
label
Cutting edge: FcγRIII (CD16) a ...... ental metastatic B16 melanoma.
@en
Cutting edge: FcγRIII
@nl
prefLabel
Cutting edge: FcγRIII (CD16) a ...... ental metastatic B16 melanoma.
@en
Cutting edge: FcγRIII
@nl
P2093
P50
P356
P1476
Cutting edge: FcγRIII (CD16) a ...... ental metastatic B16 melanoma.
@en
P2093
Andrew J Murphy
Bruno Iannascoli
David A Mancardi
Lynn E Macdonald
Marc Daëron
P304
P356
10.4049/JIMMUNOL.1201511
P407
P577
2012-11-12T00:00:00Z